Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · IEX Real-Time Price · USD
1.480
-0.030 (-1.99%)
At close: Apr 25, 2024, 4:00 PM
1.560
+0.080 (5.41%)
After-hours: Apr 25, 2024, 7:22 PM EDT
Corvus Pharmaceuticals Market Cap
Corvus Pharmaceuticals has a market cap or net worth of $72.58 million as of April 25, 2024. Its market cap has increased by 45.74% in one year.
Market Cap
72.58M
Enterprise Value
46.80M
1-Year Change
45.74%
Ranking
Category
Stock Price
$1.48
Market Cap Chart
Since March 23, 2016, Corvus Pharmaceuticals's market cap has decreased from $290.80M to $72.58M, a decrease of -75.04%. That is a compound annual growth rate of -15.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2024 | 74.00M | -1.33% |
| Apr 23, 2024 | 75.00M | 6.23% |
| Apr 22, 2024 | 70.60M | 2.77% |
| Apr 19, 2024 | 68.70M | -0.58% |
| Apr 18, 2024 | 69.10M | 3.60% |
| Apr 17, 2024 | 66.70M | -7.49% |
| Apr 16, 2024 | 72.10M | - |
| Apr 15, 2024 | 72.10M | -3.87% |
| Apr 12, 2024 | 75.00M | -1.96% |
| Apr 11, 2024 | 76.50M | 3.38% |
| Apr 10, 2024 | 74.00M | -7.38% |
| Apr 9, 2024 | 79.90M | -4.77% |
| Apr 8, 2024 | 83.90M | -2.21% |
| Apr 5, 2024 | 85.80M | 3.50% |
| Apr 4, 2024 | 82.90M | -3.38% |
| Apr 3, 2024 | 85.80M | -5.92% |
| Apr 2, 2024 | 91.20M | - |
| Apr 1, 2024 | 91.20M | 4.47% |
| Mar 28, 2024 | 87.30M | -0.57% |
| Mar 27, 2024 | 87.80M | 1.74% |
| Mar 26, 2024 | 86.30M | - |
| Mar 25, 2024 | 86.30M | -1.71% |
| Mar 22, 2024 | 87.80M | -2.66% |
| Mar 21, 2024 | 90.20M | -0.55% |
| Mar 20, 2024 | 90.70M | -5.62% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entera Bio | 72.74M |
| Cognition Therapeutics | 72.54M |
| Assembly Biosciences | 72.48M |
| Tempest Therapeutics | 71.90M |
| Genenta Science | 71.90M |
| Journey Medical | 70.56M |
| AN2 Therapeutics | 70.26M |
| Passage Bio | 70.24M |